Bogart Wealth’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Bogart Wealth's PRAX Position: Q3 2026 in Review
Bogart Wealth sold out of Praxis Precision Medicines (PRAX) in Q3 2026, closing a stake of 2 shares — an estimated $670 sold.
Bogart Wealth first reported a position in PRAX in Q1 2026 and held it in 2 quarters. The position peaked at $670 in Q2 2026. 338 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Bogart Wealth reported no remaining Praxis Precision Medicines position as of Q3 2026 after selling out during the quarter.
- Bogart Wealth sold 2 Praxis Precision Medicines shares in Q3 2026, an estimated $670.
- Bogart Wealth first reported a position in Praxis Precision Medicines in Q1 2026 and held it in 2 quarters.
- Bogart Wealth's Praxis Precision Medicines position peaked at $670 in Q2 2026.
- 338 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.